Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.

Source:http://linkedlifedata.com/resource/pubmed/id/7911241

Proc. Natl. Acad. Sci. U.S.A. 1994 Jun 7 91 12 5577-81

Download in:

View as

Triples

General Info

PMID
7911241